Product How it works Pricing Blog FAQ About Contact
Precision Biosciences

Precision Biosciences (NASDAQ: DTIL) revenue

Precision Biosciences reported revenue of $34.3m for fiscal 2025, 50.1% less than in fiscal 2024 ($68.7m). Since fiscal 2018 its revenue has grown by 214.8%, an average growth of 17.8% a year.

Precision Biosciences's best year of the last 8 was fiscal 2021. The biggest drop was in fiscal 2022, −78.3%.

Revenue, in millions of US dollars10.9201822.2201924.32020115.5202125.1202248.7202368.7202434.32025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$34.3m−50.1%−$52.1m−152.2%
2024$68.7m+41.0%−$26.2m−38.1%
2023$48.7m+94.1%−$43.7m−89.8%
2022$25.1m−78.3%−$62.3m−248.3%
2021$115.5m+375.7%−$39.4m−34.1%
2020$24.3m+9.2%−$109.8m−452.2%
2019$22.2m+104.3%−$87.2m−392.1%
2018$10.9m—−$47.9m−440.2%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Precision Biosciences revenue compared with its sector

By revenue for its latest fiscal year, Precision Biosciences ranks 346th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Precision Biosciences, −50.1%.

RankCompanyRevenueRevenue growth
344thSenseonics$35.3m56.9%
345thX4 Pharmaceuticals$35.1m1,250.5%
346thPrecision Biosciences$34.3m−50.1%
347thOrchestra BioMed$33.5m1,169.2%
348thStereotaxis$32.4m20.3%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Precision Biosciences

How much revenue did Precision Biosciences make in fiscal 2025?
Precision Biosciences reported revenue of $34.3m for fiscal 2025, compared with $68.7m in fiscal 2024.
How much has the revenue of Precision Biosciences grown?
Between fiscal 2018 and fiscal 2025 it went from $10.9m to $34.3m: 214.8% more, an average growth of 17.8% a year.
What was the best year for revenue at Precision Biosciences?
Of its last 8 fiscal years, fiscal 2021, with $115.5m.
Where does Precision Biosciences rank in its sector by revenue?
It ranks 346th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Precision Biosciences come from?
From the annual report (Form 10-K) that Precision Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Precision Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Precision Biosciences: the Precision Biosciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.